Galectin Therapeutics Ownership | Who Owns Galectin Therapeutics?

Overview Forecast RevenueFinancials Chart

Galectin Therapeutics Ownership Summary

Galectin Therapeutics is owned by 15.78% institutional investors, 30.07% insiders, and 54.16% retail investors. Vanguard group is the largest institutional shareholder, holding 3.54% of GALT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.12% of its assets in Galectin Therapeutics shares.

GALT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Galectin Therapeutics	15.78%	30.07%	54.16%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	2.25M	3.54%	$9.52M
Blackrock	1.56M	2.52%	$3.53M
Advisor group	1.22M	1.93%	$5.24M
Blackrock funding, inc. /de	797.67K	1.26%	$3.38M
Geode capital management	633.07K	1.00%	$2.68M
Marshall wace, llp	554.26K	0.87%	$2.35M
Wealthspire advisors	479.52K	0.76%	$2.03M
Lpl financial	360.27K	0.57%	$1.53M
Geneos wealth management	360.18K	0.57%	$1.53M
Commonwealth equity services	294.90K	0.46%	$1.25M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Retirement guys formula	165.99K	0.25%	$702.98K
Solutions 4 wealth	25.38K	0.17%	$107.47K
Sovran advisors	157.41K	0.07%	$798.04K
Vivaldi capital management lp	172.44K	0.05%	$363.86K
Argyle capital partners	13.38K	0.04%	$56.64K
Geneos wealth management	360.18K	0.04%	$1.53M
Gsa capital partners llp	87.09K	0.03%	$369.00K
Traynor capital management	99.10K	0.02%	$419.69K
Wealthspire advisors	479.52K	0.01%	$2.03M
Archer investment	11.00K	0.01%	$46.59K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	1.56M	0.00%	851.14K
Marshall wace, llp	554.26K	0.00%	523.86K
Vivaldi capital management lp	172.44K	0.05%	116.81K
Gsa capital partners llp	87.09K	0.03%	87.09K
Vanguard group	2.25M	0.00%	63.42K

Top Sellers

Holder	Shares	% Assets	Change
Jane street group	14.68K	-	-733.98K
Y-intercept (hong kong)	-	-	-235.19K
Atria wealth solutions	-	-	-186.00K
Soltis investment advisors	-	-	-140.75K
Ubs group	31.51K	-	-136.35K

New Positions

Holder	Shares	% Assets	Change	Value
Virtu financial	38.97K	0.01%	38.97K	$165.00K
Jefferies financial group	17.30K	0.00%	17.30K	$73.27M
Two sigma investments, lp	16.65K	0.00%	16.65K	$70.50K
Hudson bay capital management lp	14.83K	0.00%	14.83K	$62.79K
Archer investment	11.00K	0.01%	11.00K	$46.59K

Sold Out

Holder	Change
Sbi securities	-5.00
Legal & general group	-38.00
Sterling capital management	-74.00
Point72 (difc)	-187.00
Mirae asset global etfs	-374.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	87	-3.33%	10,009,146	-4.34%	15	5.76%	35	-5.41%	26	18.18%
Jun 30, 2025	88	-7.37%	9,965,158	0.59%	15	6.42%	36	24.14%	22	-26.67%
Mar 31, 2025	94	-14.55%	9,893,813	-1.83%	15	5.98%	30	-53.13%	29	222.22%
Dec 31, 2024	110	23.60%	10,078,323	3.40%	16	6.61%	64	64.10%	9	-50.00%
Sep 30, 2024	87	14.47%	9,657,327	1.46%	15	6.57%	39	-11.36%	17	112.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.36M	2.12%	-29.90K
Vanguard US Total Market Shares ETF	1.25M	1.97%	-
Vanguard Institutional Extnd Mkt Idx Tr	543.11K	0.85%	-173.52K
Fidelity Extended Market Index	268.61K	0.42%	-879.00
Fidelity Small Cap Index	142.93K	0.23%	-17.81K
iShares Russell 2000 Growth ETF	103.67K	0.16%	-
iShares Micro-Cap ETF	101.44K	0.16%	-
BlackRock Extended Equity Market K	92.01K	0.15%	-39.00
Extended Equity Market Fund K	89.26K	0.14%	-1.78K
Fidelity Total Market Index	87.23K	0.14%	-186.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 08, 2025	Shlevin Harold H.	-	Sell	$119.24K
Dec 08, 2025	Shlevin Harold H.	-	Sell	$119.24K
Dec 08, 2025	Shlevin Harold H.	-	Sell	$208.25K
Dec 08, 2025	Shlevin Harold H.	-	Sell	$210.66K
Dec 08, 2025	Shlevin Harold H.	-	Sell	$148.65K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	31
2025 Q3	2	2
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	8	3

GALT Ownership FAQ

Who Owns Galectin Therapeutics?

Galectin Therapeutics shareholders are primarily institutional investors at 15.78%, followed by 30.07% insiders and 54.15% retail investors. The average institutional ownership in Galectin Therapeutics's industry, Biotech Stocks , is 45.22%, which Galectin Therapeutics falls below.

Who owns the most shares of Galectin Therapeutics?

Galectin Therapeutics’s largest shareholders are Vanguard group (2.25M shares, 3.54%), Blackrock (1.56M shares, 2.52%), and Advisor group (1.22M shares, 1.93%). Together, they hold 8.00% of Galectin Therapeutics’s total shares outstanding.

Does Blackrock own Galectin Therapeutics?

Yes, BlackRock owns 2.52% of Galectin Therapeutics, totaling 1.56M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.53M$. In the last quarter, BlackRock increased its holdings by 851.14K shares, a 119.44% change.

Who is Galectin Therapeutics’s biggest shareholder by percentage of total assets invested?

Retirement guys formula is Galectin Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.25% of its assets in 165.99K Galectin Therapeutics shares, valued at 702.98K$.

Who is the top mutual fund holder of Galectin Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Galectin Therapeutics shares, with 2.12% of its total shares outstanding invested in 1.36M Galectin Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools